Search
Pacific Biosciences of California Inc
PACBAdd to Watchlist
1.355USD
-0.045-3.21%
Close 07-24 16:00（ET）Quotes delayed by 15 min
409.15MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-24The current earnings forecast score of Pacific Biosciences of California Inc is 7.25, ranking 149 out of 200 in the Healthcare Equipment & Supplies industry. The average price target is 2.50, with a high of 3.00 and a low of 1.00.
Analyst Rating
Based on
8
analysts
Buy
Current Rating
2.458
Target Price
+75.59%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Pacific Biosciences of California Inc
PACB
8
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Pacific Biosciences of California Inc's expected revenue for the next quarter?
Pacific Biosciences of California Inc's expected revenue is 40.16M.
What is Pacific Biosciences of California Inc's price target?
Analysts forecast that Pacific Biosciences of California Inc's price target is USD 2.50, with the highest forecast at USD 3.00 and the lowest forecast at USD 1.00.
How have Pacific Biosciences of California IncPACB's recent earnings per share performed?
The market expectation was USD -0.03, while Pacific Biosciences of California IncPACB's earnings per share (EPS) for the previous quarter was USD -0.13. EPS for the next quarter is expected at USD -0.13.
What is the analyst rating for Pacific Biosciences of California Inc?
Based on the ratings of Pacific Biosciences of California Inc's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.